Suggestions
Koeyli Jaluka
Communications - Forbes Incredible Leader - ISB - SPJIMR
Koeyli Jaluka is a seasoned professional with extensive experience in public affairs, corporate communications, and corporate social responsibility (CSR). She currently holds the position of Head of Public Affairs, Corporate Communications, and CSR at Roche, a prominent pharmaceutical company.
Professional Background
Koeyli has a diverse background in the healthcare and pharmaceutical industry. In October 2022, she was appointed as the communications head for northwestern Europe and Canada at Roche Diabetes Care, based in London.5 This role likely contributed to her current position at Roche, where she oversees multiple key areas of the company's external and internal communications strategies.
Expertise and Responsibilities
As the Head of Public Affairs, Corporate Communications, and CSR, Koeyli is responsible for:
- Managing Roche's public image and stakeholder relationships
- Overseeing corporate communications strategies
- Developing and implementing CSR initiatives
Her role likely involves crafting messaging, managing media relations, and ensuring that Roche's corporate values and social responsibility efforts are effectively communicated to both internal and external audiences.
Professional Engagements
Koeyli is active in professional circles and regularly participates in industry events. For instance, on March 24, 2024, she expressed excitement about speaking on a topic she is passionate about at an upcoming event in London on May 15.4 This engagement demonstrates her involvement in thought leadership within her field.
Online Presence
Koeyli maintains a professional presence on LinkedIn under the username koeyli-jaluka-0567763.123 Her profile serves as a platform for sharing industry insights, company updates, and personal professional achievements. She has also been recognized for her contributions to discussions on innovation in her field.3
Koeyli Jaluka's multifaceted role at Roche and her active participation in industry events indicate that she is a respected figure in the pharmaceutical communications sector, with a particular focus on public affairs, corporate communications, and corporate social responsibility.
